Acorah Software Products - Accounts Production 19.4.351 false true 31 January 2025 2 January 2024 false true No description of principal activity 1 February 2025 31 January 2026 31 January 2026 15381534 Mr Lawrence Macmillan iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15381534 2025-01-31 15381534 2026-01-31 15381534 2025-02-01 2026-01-31 15381534 frs-core:CurrentFinancialInstruments 2026-01-31 15381534 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 15381534 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 15381534 frs-bus:Micro-entities 2025-02-01 2026-01-31 15381534 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 15381534 frs-bus:Director1 2025-02-01 2026-01-31 15381534 2024-01-01 15381534 2025-01-31 15381534 2024-01-02 2025-01-31 15381534 frs-core:CurrentFinancialInstruments 2025-01-31
Registered number: 15381534
Sanare Life Sciences Limited
Financial Statements
For The Year Ended 31 January 2026
Balance Sheet
Registered number: 15381534
31 January 2026 31 January 2025
£ £
Fixed assets 968 1,600
Current assets 79,692 135,803
Creditors: Amounts Falling Due Within One Year (12,257 ) (70,812 )
NET CURRENT ASSETS 67,435 64,991
TOTAL ASSETS LESS CURRENT LIABILITIES 68,403 66,591
NET ASSETS 68,403 66,591
CAPITAL AND RESERVES 68,403 66,591

Notes

1. General Information
Sanare Life Sciences Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15381534 . The registered office is 167-169 Great Portland Street, London, W1W 5PF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Lawrence Macmillan
Director
15 October 2026